Publications by authors named "Thomas W Huizinga"

Claim this Profile
B
Baseline serum levels of cross-linked carboxy-terminal telopeptide of type I collagen predict abatacept treatment response in methotrexate-naive, anticitrullinated protein antibody-positive patients with early rheumatoid arthritis.
Chun Wu, Yanhua Hu, Peter Schafer, Sean E Connolly, Robert Wong, Thomas Wj Huizinga

RMD Open· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of tabalumab, an anti-BAFF monoclonal antibody, in patients with moderate-to-severe rheumatoid arthritis and inadequate response to TNF inhibitors: results of a randomised, double-blind, placebo-controlled, phase 3 study.
Michael Schiff, Bernard Combe, Thomas Dörner, Joel M Kremer, Thomas W Huizinga

RMD Open· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MOR103, a human monoclonal antibody to granulocyte-macrophage colony-stimulating factor, in the treatment of patients with moderate rheumatoid arthritis: results of a phase Ib/IIa randomised, double-blind, placebo-controlled, dose-escalation trial.
Frank Behrens, Paul P Tak, Mikkel Østergaard, Rumen Stoilov, Piotr Wiland, Thomas W Huizinga

Ann Rheum Dis· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Application of the 2010 ACR/EULAR classification criteria in patients with very early inflammatory arthritis: analysis of sensitivity, specificity and predictive values in the SAVE study cohort.
Iuliia Biliavska, Tanja A Stamm, Jose Martinez-Avila, Thomas W J Huizinga, Robert B M Landewé

Ann Rheum Dis· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-biomarker score measures rheumatoid arthritis disease activity in the BeSt study.
Shintaro Hirata, Linda Dirven, Yijing Shen, Michael Centola, Guy Cavet, Thomas W J Huizinga

Rheumatology (Oxford)· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Just another case of Sjogren's syndrome?
Leroy R Lard, Thomas W J Huizinga

J Rheumatol· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis.
Klaus P Machold, Robert Landewé, Josef S Smolen, Tanja A Stamm, Désirée M van der Heijde, Thomas W J Huizinga

Ann Rheum Dis· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prognostic value of baseline erosions in undifferentiated arthritis.
Mohamed M Thabet, Thomas W J Huizinga, Désirée M van der Heijde, Annette H M van der Helm-van Mil

Arthritis Res Ther· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The inflammatory disease-associated variants in IL12B and IL23R are not associated with rheumatoid arthritis.
Monica Chang, Randall K Saiki, Joseph J Cantanese, David Lew, Annette H M van der Helm-van Mil, Thomas W J Huizinga

Arthritis Rheum· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced concentrations of interleukin 16 are associated with joint destruction in patients with rheumatoid arthritis.
Leroy R Lard, Bart O Roep, Rene E M Toes, Thomas W J Huizinga

J Rheumatol· January 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis